Electrophoretic deposition of bioactive glass nanopowders on magnesium based alloy for biomedical applications
Source abstract
Abstract
Abstract To slow down the initial biodegradation rate of magnesium (Mg) alloy, crystalline nano-sized bioactive glass coating was used to deposit on micro-arc oxidized AZ91 samples via electrophoretic deposition (EPD). Zeta potential and conductivity of the bioactive glass suspension were characterized at various pH values to identify the most stable dispersion conditions. The bone-bonding properties of bioactive glass coated samples were evaluated in terms of apatite-forming ability during the immersion in simulated body fluid (SBF) solution. Results revealed that the ability to form a bioactive glass coating via EPD was influenced by the degree of its crystalline phase composition. Moreover, the potentiodynamic polarization tests recorded significant drops in corrosion current density and corrosion rate of the coated samples which implies a good level of corrosion protective behavior. These preliminary results show that this process will enable the development of Mg implants in the later stage of bone healing.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Magnesium Alloys: Properties and Applications · Layered Double Hydroxides Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Prosthetic implant materials10.1146/annurev.ms.05.080175.001431 ↗
2. Degradable biomaterials based on magnesium corrosion10.1016/j.cossms.2009.04.001 ↗
3. Evaluation of magnesium–yttrium alloy as an extraluminal tracheal stent
4. Fluoride and calcium–phosphate coated sponges of the magnesium alloy AX30 as bone grafts: a comparative study in rabbits10.1007/s10856-012-4812-2 ↗
5. Corrosion resistance and cytotoxicity of a MgF 2 coating on biomedical Mg–1Ca alloy via vacuum evaporation deposition method10.1002/sia.5257 ↗
6. Electrodeposition of hydroxyapatite coating on Mg–4.0Zn–1.0Ca–0.6Zr alloy and in vitro evaluation of degradation, hemolysis, and cytotoxicity10.1002/jbm.a.34042 ↗
7. Electrodeposition of hydroxyapatite coating on AZ91D magnesium alloy for biomaterial application10.1016/j.matlet.2008.02.048 ↗
8. Formation of Ti–Si composite oxide films on Mg–Al–Zn alloy by electrophoretic deposition and anodization10.1016/j.electacta.2005.03.010 ↗
9. The in vitro degradation process and biocompatibility of a ZK60 magnesium alloy with a forsterite-containing micro-arc oxidation coating10.1016/j.actbio.2012.12.016 ↗
10. Magnesium alloy for repair of lateral Tibial Plateau defect in Minipig model10.1016/j.jmst.2013.03.003 ↗
11. A layer-by-layer approach to natural polymer-derived bioactive coatings on magnesium alloys10.1016/j.actbio.2013.05.013 ↗
12. Influence of electrospinning and dip-coating techniques on the degradation and cytocompatibility of Mg-based alloy10.1016/j.colsurfa.2012.12.009 ↗
13. Corrosion resistance and surface biocompatibility of a microarc oxidation coating on a Mg–Ca alloy10.1016/j.actbio.2010.11.034 ↗
14. In vivo degradation performance of micro-arc-oxidized magnesium implants: a micro-CT study in rats10.1016/j.actbio.2012.09.017 ↗
15. Nanoscale bioactive glasses in medical applications10.1111/ijag.12029 ↗
16. A review of the biological response to ionic dissolution products from bioactive glasses and glass–ceramics10.1016/j.biomaterials.2011.01.004 ↗
17. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences.10.1089/ten.teb.2009.0416 ↗
18. A review of bioactive glasses: their structure, properties, fabrication, and apatite formation
19. Synthesis methods for nanosized hydroxyapatite with diverse structures10.1016/j.actbio.2013.04.012 ↗
20. Implants coated with bioactive glass by CO2-laser, an in vivo study10.1023/B:JMSM.0000032820.50983.c1 ↗
21. Sol–gel SiO2–CaO–P2O5 biofilm with surface engineered for medical application10.1590/S1516-14392007000200014 ↗
22. Electrophoretic deposition of biomaterials10.1098/rsif.2010.0156.focus ↗
23. Electrochemical and structural evaluation of functionally graded bioglass–apatite composites electrophoretically deposited onto Ti6Al4V alloy10.1016/j.electacta.2008.08.055 ↗
24. 2012
25. The dependence of the gelation time on the hydrolysis time in a two-step SiO2 sol–gel process10.1016/0022-3093(88)90309-2 ↗
26. Antibacterial effects of sol–gel-derived bioactive glass nanoparticle on aerobic bacteria10.1002/jbm.a.32678 ↗
27. A simple route to hydroxyapatite nanofibers10.1016/S0167-577X(02)00539-6 ↗
28. Electrophoretic deposition of nanostructured hydroxyapatite coating on AZ91 magnesium alloy implants with different surface treatments10.1016/j.apsusc.2013.08.108 ↗
29. A review on fundamentals and applications of electrophoretic deposition (EPD)10.1016/j.pmatsci.2006.07.001 ↗
30. Controlling the degradation rate of AZ91 magnesium alloy via sol–gel derived nanostructured hydroxyapatite coating10.1016/j.msec.2013.05.014 ↗
31. Instruments · 2004
32. Characterization of the bone-like apatite precipitated on high velocity oxy-fuel (HVOF) sprayed calcium phosphate deposits10.1016/S0142-9612(02)00413-1 ↗
33. Medical application of calcium orthophosphate bioceramics10.5618/bio.2011.v1.n1.1 ↗
34. Crystallization kinetics, mineralization and crack propagation in partially crystallized bioactive glass 45S510.1016/j.msec.2010.06.019 ↗
35. Surface chemistry of bioactive glass–ceramics10.1016/0022-3093(90)90199-V ↗
36. Can bioactivity be tested in vitro with SBF solution?10.1016/j.biomaterials.2009.01.008 ↗
37. In vitro corrosion behavior of bioceramic, metallic, and bioceramic–metallic coated stainless steel dental implants10.1016/S0109-5641(02)00029-5 ↗
38. Sintering and crystallisation of 45S5 Bioglass® powder10.1016/j.jeurceramsoc.2009.06.035 ↗
39. Calcium hydroxyapatite, Ca10 (PO4) 6 (OH) 2 ceramics prepared by aqueous sol–gel processing10.1016/j.materresbull.2006.02.016 ↗
40. Sol–gel derived nanocrystalline fluoridated hydroxyapatite powders and nanostructured coatings for tissue engineering applications10.1007/s11661-010-0465-2 ↗
41. The effect of Sr concentration on bioactivity and biocompatibility of sol–gel derived glasses based on CaO–SrO–SiO2–P2O5 quaternary system10.1016/j.msec.2009.12.001 ↗
42. Formation of a high-strength bioactive glass–ceramic in the system MgO–CaO–SiO2–P2O510.1007/BF01145520 ↗
43. Sol−gel glasses as precursors of bioactive glass ceramics10.1021/cm021325c ↗
44. The influence of phosphorus precursors on the synthesis and bioactivity of SiO2–CaO–P 2O 5 sol–gel glasses and glass–ceramics10.1007/s10856-012-4797-x ↗
45. Characterization of some bioglass–ceramics10.1016/S0254-0584(03)00082-8 ↗
46. Crystallization kinetics of tape cast bioactive glass 45S510.1016/S0022-3093(02)01857-4 ↗
47. Preparation of hydroxyapatite via microemulsion route10.1016/S0021-9797(02)00233-3 ↗
48. Corrosion mechanisms of magnesium alloys10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N ↗
49. Biofunctionalization of porous titanium coatings through sol–gel impregnation with a bioactive glass–ceramic10.1016/j.msec.2012.06.017 ↗
50. In vitro dissolution of melt-derived 45S5 and sol–gel derived 58S bioactive glasses10.1002/jbm.10207 ↗
51. Fabrication and in vitro biomineralization of bioactive glass (BG) nanofibres10.1088/0957-4484/18/13/135601 ↗
52. Fourier transform infrared spectroscopic characterization of dergaon H5 chondrite: evidence of aliphatic organic compound
53. Characteristics of bioactive glass coatings obtained by pulsed laser deposition10.1002/sia.2925 ↗
54. FTIR, XRD, SEM and solid state NMR investigations of carbonate-containing hydroxyapatite nano-particles synthesized by hydroxide–gel technique10.1016/S0022-3697(02)00257-3 ↗
55. Electrophoretic deposition of hydroxyapatite coatings on titanium from dimethylformamide suspensions10.1016/j.surfcoat.2011.06.034 ↗
56. Thick hydroxyapatite coatings by electrophoretic deposition10.1016/S0167-577X(02)00706-1 ↗
57. Zeta potential of apatite in aqueous solutions and its change during equilibration10.1016/0021-9797(68)90098-2 ↗
58. The effect of bioactive glasses on bone marrow stromal cells differentiation10.1016/j.biomaterials.2004.09.059 ↗
59. In vitro bioactivity of glass and glass-ceramics of the 3CaO·P2O5–CaO·SiO2–CaO·MgO·2SiO2 system10.1016/S0142-9612(99)00150-7 ↗
60. 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering10.1016/j.biomaterials.2005.11.025 ↗
61. Ordered mesoporous bioactive glasses for bone tissue regeneration10.1021/cm060488o ↗
62. Mechanism of apatite formation on CaO–SiO2–P2O5 glasses in a simulated body fluid10.1016/S0022-3093(05)80556-3 ↗
63. The effects of surface and biomolecules on magnesium degradation and mesenchymal stem cell adhesion10.1002/jbm.a.33188 ↗
64. Trace elements in human physiology and pathology: zinc and metallothioneins10.1016/S0753-3322(03)00081-7 ↗
65. Aluminium levels in Italian diets and in selected foods from aluminium utensils10.1080/02652039609374464 ↗